The antitumor antibiotic rebeccamycin—challenges and advanced approaches in production processes
Authors:
- 19 March 2019
- journal article
- review article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 103 (9) , 3627-3636
Abstract
Rebeccamycin is an antibiotic and antitumor substance isolated from the filamentous bacterium Lentzea aerocolonigenes. After its discovery, investigations of rebeccamycin focused on elucidating its structure, biological activity, and biosynthetic pathway. For potential medical application, a sufficient drug supply has to be ensured, meaning that the production process of rebeccamycin plays a major role. In addition to the natural production of rebeccamycin in L. aerocolonigenes, where the complex cell morphology is an important factor for a sufficient production, rebeccamycin can also be heterologously produced or chemically synthesized. Each of these production processes has its own challenges, and first approaches to production often lead to low final product concentrations, which is why process optimizations are performed. This review provides an overview of the production of rebeccamycin and the different approaches used for rebeccamycin formation including process optimizations.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG Priority Programme 1934 DiSPBiotech – Dispersity, structural and phase modifications of proteins and biological agglomerates in biotechnological processes)
This publication has 49 references indexed in Scilit:
- Phase-II Trial of Rebeccamycin Analog, a Dual Topoisomerase-I and -II Inhibitor, in Relapsed “Sensitive” Small Cell Lung CancerJournal of Thoracic Oncology, 2012
- Mycelium Differentiation and Antibiotic Production in Submerged Cultures ofStreptomyces coelicolorApplied and Environmental Microbiology, 2008
- Microparticle‐enhanced cultivation of filamentous microorganisms: Increased chloroperoxidase formation by Caldariomyces fumago as an exampleBiotechnology and Bioengineering, 2007
- Effect of Various Process Parameters on Morphology, Rheology, and Polygalacturonase Production byAspergillus sojaein a Batch BioreactorBiotechnology Progress, 2007
- Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedulesInvestigational New Drugs, 2006
- Oxygen profiles and biomass distribution in biopellets of Aspergillus nigerBiotechnology and Bioengineering, 2005
- Characterization of the Biosynthetic Gene Cluster of Rebeccamycin fromLechevalieria aerocolonigenesATCC 39243Bioscience, Biotechnology, and Biochemistry, 2003
- Revival of the genus Lentzea and proposal for Lechevalieria gen. nov.International Journal of Systematic and Evolutionary Microbiology, 2001
- Synthesis of Rebeccamycin and 11-DechlororebeccamycinThe Journal of Organic Chemistry, 1999
- Transfer of "Nocardia aerocolonigenes" (Shinobu and Kawato 1960) Pridham 1970 into the Genus Saccharothrix Labeda, Testa, Lechevalier, and Lechevalier 1984 as Saccharothrix aerocolonigenes sp. nov.International Journal of Systematic and Evolutionary Microbiology, 1986